Exact Sciences Corporation (EXAS)

65,35 -5,99 (-8,40%) Alla chiusura: 04:00PM EDT

Exact Sciences Corporation

5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700
https://www.exactsciences.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 6.500

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Kevin T. Conroy	Chairman of The Board & CEO	1,54M	26,75M	1966
Mr. Jeffrey T. Elliott CFA	EVP & CFO	518,13k	N/D	1978
Ms. Sarah Condella	Executive Vice President of Human Resources	742,76k	N/D	1981
Mr. Everett V. Cunningham	Chief Commercial Officer	1,34M	N/D	1966
Dr. Jorge A. Garces Ph.D.	Chief Science Officer	N/D	N/D	1972
Mr. Nassar Nizami	Chief Information Officer	N/D	N/D	N/D
Ms. Megan Jones	Associate Manager of Investor Relations	N/D	N/D	N/D
Mr. Tim Caprez	Chief Compliance Counsel & VP	N/D	N/D	N/D
Mr. James Herriott	Senior VP, General Counsel & Secretary	N/D	N/D	1980
Mr. Vic Parker	Head of Sales	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Governance aziendale

L'ISS Governance QualityScore di Exact Sciences Corporation al 1 aprile 2024 è 3. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 5; diritti degli azionisti: 3; retribuzione: 7.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.